PHANZ COUNCIL ELECTION RESULTS 2020

16 Nov 2020 11:55 AM | Anonymous

We are pleased to announce that the following nominations received for the vacancies on the PHANZ board are now declared elected as per 11.1 of the PHANZ Election bylaw, and will commence their tenure at the PHANZ AGM Dec 2nd 2020. 

11. WHERE VACANCIES EXCEED NUMBER OF CANDIDATES
11.1 If the number of candidates nominated does not exceed the number of vacancies to be filled, the Returning Officer shall declare the candidate or candidates nominated elected.

Maxine Shortland (President)**Should  proposed remit 1  be ratified at the PHANZ AGM Dec 2nd 2020 then this position will become entrenched in our constitution as a Co-President in Te Tiriti based partnership with the Co-President Māori.  The change would occur at the 2021 AGM with interim arrangements made toward that end by the incoming council.
Toni Paterson (General Executive)  
Jalal Mohammed (General Executive) 
Gail Duncan (General Executive) 

We welcome our new executives to the team, for bios click here

The PHA – a strong and informed collective voice for a healthy and well New Zealand.

Privacy | Contact

Copyright © Public Health Association of New Zealand 2016

Log in

Letter to the Listener 28 July 2017 in response to Fever Pitch (Listener 21 July 2017)

Catherine Woulfe’s thorough investigation of rheumatic fever brings to the surface a range of important questions not only about this cruel disease, but also wider issues about health policy. The Government’s bold initiative to reduce the incidence of rheumatic fever as one of its 'Better Public Service' targets in 2012 certainly raised awareness of rheumatic fever for the general public as well as communities and families directly affected. But even when medical science and the public have a clearer understanding of the immediate causes of rheumatic fever, interventions like the $65m ‘sore throats matter’ still won’t stop the epidemic. 

Ramona Tiatia’s blunt description of the experience of affected families not only painted a picture of the impact on affected families and communities, it also highlighted the invidious choices our health funders face.  How much should we prioritise health spending between response to the urgent need of young people whose lives and potential can be devastated by the disease versus the expense of addressing the economic and social factors that underlie the reasons we have this epidemic at all?   

As several of the clinicians interviewed pointed out, it’s only when the poverty and over-crowded housing issues are addressed that we will make a real difference.

Rheumatic fever illustrates the contradictions in our health system identified in the recent American Commonwealth Fund report. Of the 11 countries the Fund monitors, the work our health professionals do is ranked among the highest. But our overall performance as a health system falls to the middle ranking because of our poor performance on access and equity. The Fund also notes that our per capita expenditure is among the cheapest. 

Failure to invest in real prevention - that is, poverty, housing, good nutrition etc. - will continue to drive conditions like rheumatic fever, whether the immediate cause is strep throat or skin sores, until we invest upstream.

Why not spend more on these conditions - the economic and social determinants of health? 

We all pay in the long run - the young people whose misery we tolerate and whose potential remains unfulfilled, the families whose sacrifices are unrewarded, and the taxpayer who picks up the tab.

Ngā mihi,
Warren Lindberg

CE Public Health Association of New Zealand

                                            

Powered by Wild Apricot Membership Software